Arsenic trioxide (As 2 O 3 ) is toxic to multidrug-resistant neuroblastoma cells in vivo and in vitro. In neuroblastoma, As 2 O 3 does not exert its cell death-promoting effects via a classical apoptotic pathway. A death mechanism involving proteolytic cleavage of Bax to a p18 form seems to be of importance, because inhibition of Bax cleavage coincides with diminished cell death. As existing models of cell death implicate Bax in the intrinsic apoptotic pathway, triggering death after Bax translocation to the mitochondria, we investigated the cellular localization of p18 Bax by subcellular fractionation. After As 2 O 3 treatment, p18 Bax was only present in nuclei-enriched, mitochondriadepleted fractions. Cytoplasmic p21 Bax levels decreased, whereas total (p21 and p18) nuclear Bax increased. Overexpressed p21 Bax localized to the cytoplasm and nuclei, whereas overexpressed p18 Bax localized to extranuclear structures only. The inability of overexpressed p18 Bax to locate to the nucleus, and the As 2 O 3 -induced reduction of p21 Bax in the cytosol, suggest an As 2 O 3 -induced mechanism where p18 Bax gets cleaved and 'trapped' in the nucleus. This model is strengthened by the observation that calpain, the protease responsible for p18 Bax generation, is present in the nuclei, and that nuclear calpain is induced by increasing As 2 O 3 and Ca 2 þ levels.
Introduction
Neuroblastoma is the most common extracranial solid tumour diagnosed during early childhood. Despite large efforts, approximately 50% of the affected children die from their disease (Philip et al., 1997; Matthay et al., 1999) . The survival rate of children over 1 year of age with advanced tumours (Stage 4), which are characterized by widespread growth, is less than 20% (Pearson and Philip, 2000) . Although virtually all neuroblastomas respond well to induction therapy, most high-stage neuroblastomas relapse and after multiple rounds of chemotherapy, the tumours often become multidrugresistant. The mechanism(s) behind therapy-induced drug resistance in neuroblastoma is not known, but relapsing tumours can gain inactivating p53 mutation(s), contrasting the virtual lack of p53 mutations in neuroblastomas at the time of diagnosis (Keshelava et al., 2001; Tweddle et al., 2001) . The multidrugresistance seen in patients with relapsed neuroblastomas is also reflected in the poor drug sensitivity of many established human neuroblastoma cell lines used as model systems to study neuroblastoma drug resistance mechanisms (Keshelava et al., 1998) . Arsenic trioxide (As 2 O 3 ) can kill multidrug-resistant human neuroblastoma cells in vitro both at normoxia (21% O 2 ) and hypoxia (1% O 2 ) (Øra et al., 2000; Karlsson et al., 2004 Karlsson et al., , 2005 . The drug is efficient also in vivo as demonstrated in a neuroblastoma animal model (Øra et al., 2000) . A Phase I and an ongoing Phase II clinical trial at the Memorial Sloan-Kettering Cancer Center, New York, have shown tumour response with low toxicity in children with relapsed neuroblastoma treated with As 2 O 3 (BH Kushner and N-K Cheung, personal communication) . These findings suggest a potential clinical use of As 2 O 3 in the treatment of multidrugresistant neuroblastomas.
As 2 O 3 is used as first-line treatment modality in patients with relapsed acute promyelocytic leukaemia (Shen et al., 1997; Soignet et al., 1998; Niu et al., 1999; Cohen et al., 2001) . A direct As 2 O 3 -induced cytotoxic effect triggered by mitochondria-induced mechanisms has been proposed in cultured cells (Cai et al., 2000) , but growth inhibition and induced tumour cell differentiation have also been implicated (Zhang et al., 2001; Miller et al., 2002) . The death mechanisms triggered by As 2 O 3 in multidrug-resistant neuroblastoma cells are far from known. At clinically relevant concentrations, substantial cell death first occurs after 24 h and becomes more prominent after several days of treatment. At the molecular level, the death appears not to involve a classical intrinsic mitochondrial pathway as only a fraction of the mitochondrial cytochrome c becomes cytoplasmic, and inhibition of caspases, including caspase 3, does not prevent or reduce cell death (Karlsson et al., 2004) . The As 2 O 3 -induced neuroblastoma death is accompanied by a calpain-dependant proteolytic activation of p21 Bax to a p18 form (Karlsson et al., 2004) , which in other cell systems has been shown to be an N-terminal truncation leading to a more pro-apoptotic form (Gao and Dou, 2000; Wood and Newcomb, 2000; Choi et al., 2001; Cao et al., 2003; Toyota et al., 2003; Cartron et al., 2004) . In neuroblastoma cells, inhibition of calpain activity prevented formation of p18 Bax and As 2 O 3 -induced cell death. We further showed that p18 Bax localized to a mitochondria-enriched particulate fraction and was, as opposed to p21 Bax, not present in the cytosol (Karlsson et al., 2004) . Based on these observations and data in the literature, we postulated that p18 Bax is localized to, and exerts its effect in the mitochondria.
Two calpain-generated p18 Bax forms, lacking either aa 1-28 or aa 1-33, have been suggested (Wood et al., 1998; Cao et al., 2003; Toyota et al., 2003) . Most reports find that p18 Bax localizes to the mitochondrion (Wood et al., 1998; Gao and Dou, 2000; Choi et al., 2001; Cao et al., 2003; Oh et al., 2004) . However, transfection of Bax À/À cells with Bax lacking aa 1-37, revealed that the truncated Bax did not localize to mitochondria and that the truncated form was less pro-apoptotic than p21 Bax (Cartron et al., 2003) , observations in disagreement with published data and also with our own hypothesis that p18 Bax becomes localized to mitochondria in As 2 O 3 -treated neuroblastoma cells (Karlsson et al., 2004) . Thus, the observation by Cartron et al. (2003) and the suggestions by other groups that p18 Bax acts via mitochondria-induced cell death, prompted us to investigate in more detail the subcellular localization of p18 as well as p21 Bax in non-and As 2 O 3 -treated human neuroblastoma cells. Unexpectedly, we find that p18 Bax is exclusively present in a nuclei-enriched, mitochondria-depleted fraction. Overexpression of p21 Bax revealed either a diffuse Bax distribution in the entire cell, including the nuclei, or a punctuate mitochondrial localization. In contrast, overexpressed p18 Bax was only found in extra-nuclear, mito-and lysotracker-negative structures of presumably dying cells. As calpains were abundant in the nucleus and we could stimulate nuclear calpain and Bax cleavage by Ca 2 þ and As 2 O 3 , we postulate that endogenous p18 Bax is generated in the nuclei and exerts its death-promoting effect(s) at this site.
Results
As 2 O 3 -treated dead neuroblastoma cells mainly contain p18 Bax Treatment of neuroblastoma cells with As 2 O 3 results in cell death and cells become non-adherent. To further establish that p18 Bax is associated with cell death in As 2 O 3 -treated neuroblastoma cells, the p18 and p21 Bax status was analysed in floating and adherent cells. Virtually all Bax protein was in the p18 form in the floating cells (>97% dead cells defined as Trypan blue positive) (Figure 1a) . Furthermore, essentially all immunodetectable PARP was in a cleaved form in the floating cells, further supporting the conclusion that this cell population consists of mostly dead cells. No As 2 O 3 -induced 50 kD PARP fragment, indicative of necrotic cell death (Shah et al., 1996; Gobeil et al., 2001) , could be detected. p18 Bax was also found in the adhering cell population but at significantly lower levels than in floating cells, which suggest that the generation of p18 Bax precedes cell death and could be an early event in the death-promoting process.
Subcellular localization of p21 Bax, p18 Bax, cytochrome c, prohibitin and calnexin We have previously reported that p18 Bax generated during As 2 O 3 treatment, as opposed to p21 Bax, is exclusively present in a particulate and not in a mitochondria-and nuclei-depleted cytosolic fraction. We hypothesized that As 2 O 3 -induced p18 Bax, being a pro-apoptotic 'activated' form, localizes to mitochondria (Karlsson et al., 2004) . However, it was recently inferred that p18 Bax lacks the mitochondrial localization signal, which prompted us to analyse in more detail the subcellular localization of As 2 O 3 -generated p18 Bax, as Bax can localize to the cytosol, mitochondrion, nucleus (Mandal et al., 1998; Ho et al., 1999; Raffo et al., 2000) and endoplasmic reticulum (ER) (Breckenridge et al., 2003; Scorrano et al., 2003) . To study the Bax subcellular localization, we separated these compartments by classical centrifugation approaches. By one of several protocols tested (protocol I), that is, swelling of the cells in hypotonic buffer and Dounce homogenization followed by removal of the nuclei by gentle centrifugation, nuclear fractions virtually free of contaminating cytosol and mitochondria were obtained (Figure 1b) . Although the nuclear fraction was devoid of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and cytochrome c (cytosolic and mitochondrial markers, respectively), the nuclear protein lamin B was only present in the nuclear fraction. Unexpectedly, p18 Bax distributed as lamin B suggesting an almost exclusive nuclear localization, whereas p21 Bax was found in both the nuclear and in the residual fraction containing cytosol, mitochondria and light membrane structures. Importantly, the amount of p18 Bax increased in the nuclear fractions in As 2 O 3 -treated cells (Figure 1b) .
The fractions were analysed for the presence of calnexin, an established ER marker. Calnexin was found in both fractions (Figure 1b) , a result either explained by ER being present in the nuclei fraction or by a de facto nuclear localization of calnexin. We further found that also the mitochondrial marker prohibitin was present in both fractions, including the nuclei-enriched, cytochrome c-free fraction (Figure 1b) . Clearly, the subcellular distribution of the mitochondrial markers cytochrome c and prohibitin do not fully agree, but in other cell systems a fraction of prohibitin has been shown to be nuclear (Wang et al., 2002; Mishra et al., 2005) .
By immunofluorescence and confocal microscopy, Bax was found both in the cytoplasm and in the nucleus (Figure 1c ), whereas cytochrome c as expected colocalized with the mitochondrial marker dye Mitotracker Red (MT) (Molecular Probes, Eugene, OR, USA) and was not present in the nuclei (Figure 1d ). In agreement with the fractionation data and published data, prohibitin was found in both cytoplasm and nuclei ( Figure 1e ). The cytoplasmic prohibitin was clearly enriched in MT positive (MT þ ) structures, confirming that prohibitin to a large extent is mitochondrial (see merge with the MT staining). Calnexin immunoreactivity was primarily found outside the nucleus and in contrast to prohibitin, calnexin did not co-localize with MT þ structures ( Figure 1f ). In addition, calnexin was highly enriched in the nuclear membrane and faint staining was seen throughout the nucleus. This result is in agreement with current models in which the ER and the nuclear membrane are a continuum (Mattaj, 2004) . Hence, the immunofluorescence data are in agreement with and support the marker protein distribution observed in the subcellular fractionation experiments (Figure 1b ).
Localization of overexpressed p21 and p18 Bax-EGFP fusion proteins
To further analyse the localization of the two Bax forms, expression plasmids encoding p18 or p21 Bax fused either N-or C-terminally to EGFP were generated Arsenic trioxide-induced neuroblastoma cell death J Karlsson et al (Table 1a) , and neuroblastoma cells were transiently transfected with these constructs. p21 Bax-EGFP displayed two distinguished localization patterns, it was either enriched in punctuate, distinct cytoplasmic structures or diffusely distributed in both nucleus and cytoplasm (3474 and 6674% of transfected cells, respectively). We next tested to what extent p21 Bax-EGFP localized to the mitochondria by co-staining with MT (Figure 2a-c) . In cells with diffuse cytoplasmic and nuclear p21 Bax-EGFP signal, a slight enrichment in MT þ structures was seen, indicating that a fraction of overexpressed p21 Bax was mitochondrial, and that cytoplasmic p21 Bax also was present in non-MT þ structures. In a subset of cells, the punctuate fluorescence co-localized with MT (Figure 2b and c) . Similar localization patterns of overexpressed p21 Bax were obtained irrespective of whether EGFP was fused N-or C-terminally of Bax (data not shown). As two cleavage sites generating p18 Bax have been suggested (Wood et al., 1998; Cao et al., 2003; Toyota et al., 2003) , we generated vectors encoding p18 Bax starting either at aa 29 or 34 (Table 1a) . Irrespective of construct used and whether EGFP was fused at the N-or C-terminus, overexpressed p18 Bax located in extra-nuclear punctuate structures (Figure 2d and e, data not shown). Costaining with propidium iodide confirmed that p21-but not p18 Bax EGFP fusion proteins can localize to the nucleus (Figure 2e ). The p18 Bax-EGFP fluorescence appeared not to localize to functional mitochondria as the EGFP positive cells were MT-negative (Figure 2d) , and mitochondrial uptake of the MT stain only occurs in mitochondria with intact membrane potential (Poot et al., 1997) . By immunostaining, there was no substantial co-localization between p18 Bax-EGFP and the mitochondrial markers cytochrome c and prohibitin, suggesting that at most a small fraction of exogenous p18 Bax ended up in the mitochondria (data not shown). In dying cells, Bax can localize to lysosomes (Feldstein et al., 2004) , but co-staining with the lysosomal marker Lysotracker showed no overlap with p18-EGFP Bax fluorescence (data not shown). To summarize this set of data, overexpressed p18 Bax could not translocate to the nucleus, suggesting that generation of p18 Bax, as such, does not result in a Bax structure that promotes a nuclear localization.
Bcl-2 overexpression inhibits p21 but not p18 Bax-induced cell death As the p18 Bax-transfected cells had a rounded morphology and were MT negative, our data suggest that overexpression of p18 Bax results in cell death. To test whether the cell death induced by overexpressed Bax can be inhibited by Bcl-2, Bax plasmids were cotransfected with Bcl-2 and the number of TUNELpositive EGFP þ cells was scored. Overexpressed Bcl-2 rescued p21 Bax, but did not rescue p18 Bax-transfected cells to any significant degree (Figure 3) . Thus, both subcellular localization and the divergent responses to Bcl-2 overexpression suggest that p21 and p18 Bax have different functions as mediators of cell death.
Endogenous p18 Bax is generated in the nucleus In As 2 O 3 -treated neuroblastoma cells, a small increase in total Bax protein levels was observed (Karlsson et al., 2004) , which did not reflect an increased Bax transcription ( Figure 4a ). Cytoplasmic p21 Bax levels decreased slightly in As 2 O 3 -treated cells, whereas total particulate/nuclear Bax (p21 and p18 forms) increased (Figure 4b and c) . The facts that endogenous, but not exogenous p18 Bax was nuclear, exogenous p21 Bax can translocate to the nucleus and cytoplasmic p21 Bax decreased in As 2 O 3 -treated cells suggested that generation of p18 Bax in As 2 O 3 -treated cells occurs in the nucleus. As 2 O 3 -induced cleavage of Bax in neuroblastoma cells is dependant on calpain activity as demonstrated previously (Karlsson et al., 2004) . As shown here by immunofluorescence, nuclear calpain immunoreactivity is abundant in treated and untreated neuroblastoma cells (Figure 5a ). Calpains are activated by proteolytic cleavage in a Ca 2 þ -dependant process (Friedrich, 2004) . However, increasing Ca 2 þ concentrations did not induce calpain cleavage in isolated neuroblastoma nuclei (Figure 5c ). The death-promoting effect of clinically relevant concentrations of As 2 O 3 is a comparatively late event, and when As 2 O 3 is washed away after 12 h of treatment, neuroblastoma cell death is drastically diminished when compared to cultures exposed to As 2 O 3 for the entire culture period (Figure 5b ), indicating that As 2 O 3 requires an initial priming phase to be toxic. We therefore tested if pre-treatment of cells with 2 mM As 2 O 3 for 12 h could trigger Ca 2 þ -induced calpain 
c). p18(D1-28)Bax-EGFP only distributed to punctuate extra-nuclear Mitotracker negative structures (d). SK-N-BE(2)c cells with overexpressed p21 Bax and p18 Bax fused C-terminally to EGFP gave similar distribution patterns as Bax fused N-terminally to EGFP (data not shown). (e) Transfection with two EGFP-p18
Bax constructs (D1-28 and D1-33) resulted in the same distribution pattern. Propidium iodide (PI) staining shows that the EGFP-p21 Bax as opposed to the EGFP-p18 Bax fusion protein localizes to the nucleus.
Arsenic trioxide-induced neuroblastoma cell death J Karlsson et al cleavage assayed after additional 60 h of culture. In these As 2 O 3 -primed cells, a Ca 2 þ -driven cleavage of the small 30 kDa calpain subunit, a subunit common to both m-and m-calpain (Goll et al., 2003) , could be detected (Figure 5c ). In addition, nuclear calpain was cleaved and activated by As 2 O 3 treatment (Figure 5d ), further supporting that p18 Bax is generated in neuroblastoma nuclei as a result of As 2 O 3 exposure. Finally, using isolated nuclei from As 2 O 3 -pre-treated cells stimulated with Ca 2 þ in vitro, we confirmed that inhibition of calpain activity by calpeptin resulted in an abolished As 2 O 3 -induced p21 to p18 Bax cleavage ( Figure 5e ).
Discussion
During treatment, neuroblastoma patients frequently develop multidrug resistance, which is reflected in some established neuroblastoma cell lines. The capacity of As 2 O 3 to kill drug-resistant neuroblastoma cells forms the basis for our interest in cell death mechanisms induced by this drug. The mechanism by which As 2 O 3 kills neuroblastoma and other tumour cells is not known in detail, and the response to As 2 O 3 might differ from one tumour form to another. For instance, unlike APL cells, neuroblastoma cells seem not to differentiate in response to As 2 O 3 (Øra et al., 2000) . In neuroblastoma, caspase activation is not essential, as inhibition could not prevent As 2 O 3 -induced cell death. However, the pro-apoptotic Bax protein became activated and cleaved to a p18 form during As 2 O 3 exposure, and this process as well as cell death could be significantly impaired by calpain inhibition (Karlsson et al., 2004) . Thus, proteolytic activation of Bax appears to be essential for As 2 O 3 toxicity. The strongest arguments for this conclusion are the reported findings (1) that p18 Bax is more pro-apoptotic than p21 Bax, (2) our previous finding that inhibition of calpains leads to blocked p18 Bax formation and partially inhibited cell death of As 2 O 3 -treated Regarding Bax-induced death mechanisms, consensus seems to be that Bax acts in the intrinsic mitochondrial apoptotic pathway triggering cytochrome c release, assembly of the apoptosome, and caspase activation (Green and Reed, 1998) . As judged from published data, also the truncated and activated form of Bax, p18 Bax, appears to act within the intrinsic pathway (Gao and Dou, 2000; Wood and Newcomb, 2000) . Based on these reports and our own observation that p18 Bax localized to a mitochondria-enriched fraction (that also contained the nuclei), we hypothesized that the As 2 O 3 -generated p18 Bax in neuroblastoma cells functioned through mitochondrial-mediated death mechanisms (Karlsson et al., 2004) . One problem with this interpretation is that As 2 O 3 -induced neuroblastoma cell death is independent of caspases. Furthermore, a model in which p18 Bax localizes to the mitochondria of As 2 O 3 -treated neuroblastoma cells is not in keeping with a non-mitochondrial, caspase-independent cell death. The more detailed subcellular fractionation study supplemented with immunofluorescence data reported here provides an explanation for the apparent contradiction by showing that p18 Bax in drug-treated neuroblastoma cells is exclusively found in nuclei, and not in mitochondria.
Overexpression of either p21 or p18 Bax confirmed previous reports that Bax in high concentrations is cytotoxic. Our results also show that p18 and p21 Bax, when overexpressed, appear to trigger different death pathways, as p21 but not p18 Bax-induced death can be reduced by Bcl-2. However, the important information gained from overexpressing EGFP-Bax fusion genes in relation to our initial question was that exogenous p18 Bax is restricted in its localization to cytosolic structures, whereas exogenous and endogenous p21 Bax is widely distributed, and can translocate to the nucleus. Thus, Bax overexpression together with subcellular localization data strongly suggest that endogenous p18 Bax is generated within the nucleus by proteolytic cleavage of p21 Bax in drug-treated cells. This conclusion is based on the observations that endogenous p18 Bax in our experiments was never found outside the nucleus, and that nuclear calpain is abundant and activated by As 2 O 3 in neuroblastoma cells. The accumulation of p18 Bax in nuclei of As 2 O 3 -treated cells further suggests that p18 Bax becomes trapped in the nucleus, which could be a direct consequence of losing the first a-helix sequence, which seems to be important for the subcellular localization of Bax (Cartron et al., 2003 (Cartron et al., , 2004 . Alternatively, the truncated Bax variant might form complex(es) with nuclear proteins due to structural changes. If this is the case, the identification (2)c cells were grown72 mM As 2 O 3 for 12 h. Nuclei were isolated (protocol I) and treated with Ca of these structures might provide information as to the function of nuclear Bax. Translocation to the nucleus and activation of proteins involved in cell death processes is not unique to Bax. For instance, apoptosis-inducing factor also moves to the nucleus during the execution phase of apoptosis (Susin et al., 1999) .
As 2 O 3 in clinically relevant doses (corresponding to approximately 5 mM under culture conditions) induces a comparatively slow death, and few dead cells are seen after 24 h of treatment. Here, we show that activation of nuclear calpains by Ca 2 þ requires a priming phase of As 2 O 3 treatment. Thus, a key event during As 2 O 3 -induced cell death might be the triggering of nuclear calpains, as calpain inhibition is accompanied by rescue of cells from induced death (Karlsson et al., 2004) . Cytotoxic generation of p18 Bax is not restricted to As 2 O 3 as drugs like etoposide, doxorubicin, vincristine and carboplatin also induce Bax cleavage in non-multidrug-resistant neuroblastoma cells (Karlsson et al., 2004) . Whether priming of multidrug-resistant neuroblastoma cells by As 2 O 3 will make these cells sensitive to etoposide and other established cytotoxic drugs is an open question. Identification of mechanisms that activate nuclear calpains is an important topic for future investigations and might provide clues as to the mechanisms contributing to multidrug resistance, and might further highlight a novel death mechanism induced by cytotoxic drugs.
Materials and methods
Cell culture, viability assays and transfections Growth conditions of SK-N-BE(2)c neuroblastoma cells, treatment with As 2 O 3 and cell viability assays using the MTT method (CellTiter 96; Promega, Madison, WI, USA) (ATCC, Manassas, VA, USA) have been described (Karlsson et al., 2004 (Karlsson et al., , 2005 . For transfection experiments, cells were seeded on cover slips. Transfection was initiated 24 h after seeding by changing to serum-free medium and addition of 1 mg plasmid DNA and Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. Cells were fixed 16 h after transfection in 4% paraformaldehyde in phosphate-buffered solution (PBS) for 4 min, and mounted in polyvinylalcohol-diazabicyclo octane (PVA)-DABCO (9.6% polyvinyl alcohol, 24% glycerol and 2.5% 1,4 diazabicyclo (2.2.2) octane in 67 mM Tris-HCl, pH 8.0).
Subcellular fractionation
Protocol I To obtain nuclei-enriched, mitochondria-free fractions, cells were incubated on ice for 10 min in 10 mM NaCl, 1.5 mM MgCl 2 , 10mM Tris-HCl, pH 7.5, and Complete Protease Inhibitor (Roche, Molecular Biochemicals, Mannheim, Germany). Cells were homogenized with 20 strokes in a Dounce tight-fitting homogenizer and the homogenate was adjusted to 0.25 M sucrose, 1 mM ethylene glycol tetraacetic acid (EGTA) and 1 mM ethylenediaminetetraacetic acid (EDTA). Nuclei and intact cells were brought down at 500 g for 3 min at 41C, leaving mitochondria in the supernatant. To remove residual nuclei, the supernatant was centrifuged again at 500 g for 3 min at 41C (nuclei-depleted fraction containing cytosol, membranes, light organelles and mitochondria). The pellet from the first centrifugation was washed in PBS, and re-suspended in RIPA (radioimmuno precipitation assay) buffer (10 mM Tris-HCl (pH 7.2), 160 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 1 mM EGTA and 1 mM EDTA in the presence of Complete Protease Inhibitor). Samples were gently shaken for 15 min, and centrifuged at 15 000 g for 15 min at 41C. The supernatant was used as a nuclei-enriched fraction.
Protocol II
To obtain cytosolic (mitochondria and nuclei-free) and particulate (mitochondria and nuclei-enriched) fractions, cells were treated as described in Karlsson et al. (2004) . In essence, cells were re-suspended in ice-cold extraction buffer (50 mM PIPES pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM dithiolthreitol and Complete Protease Inhibitor containing 0.25 M sucrose), incubated on ice for 30 min, shaken and subsequently centrifuged at 16 000 g at 41C for 30 min. The supernatant was recovered (cytosolic fraction including light, e.g., plasma, membranes). The pellet was re-suspended in extraction buffer containing 0.1% Nonidet P-40, incubated on ice for 20 min, and centrifuged at 16 000 g (41C) for 10 min (particulate fraction containing mitochondria and nuclei).
Ca
2 þ -induced activation of calpain in nuclei preparations Nuclei-enriched, mitochondria-free preparations (protocol I) of SK-N-BE(2)c cells, treated or not treated with As 2 O 3 for 12 h, were incubated for 8 h at 371C at increasing concentrations of CaCl 2 dissolved in PBS with or without the calpain inhibitor calpeptin (Calbiochem, Merck KgaA, Darmstadt, Germany). The reactions were terminated by centrifugation and lysis of the pellets in RIPA buffer with protease inhibitors as above. The lysates were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot.
Western blot analysis
Western blot analyses were performed as described in Karlsson et al. (2004) using the following primary antibodies/antisera; anti-Bax antiserum (BD Pharmingen, San Diego, CA, USA developed against an aa 43-61 peptide of human Bax) diluted 1:2000, anti-calnexin antibody (Chemicon International Inc., Temecula, CA, USA) diluted 1:250, anti-calpain small subunit antibody (Chemicon) diluted 1:500, anti-cytochrome c antibody (BD Pharmingen) diluted 1:1000, anti-GAPDH antibody (Chemicon) diluted 1:1000, anti-prohibitin antibody (NeoMarkers, Fremont, CA, USA) diluted 1:100, anti-lamin B antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) diluted 1:5000, anti-actin antibody (ICN Biomedicals, Irvine, CA, USA) diluted 1:3000 and anti-PARP antibody (Biomol Research Laboratories Inc., Plymouth Meeting, PA, USA) diluted 1:5000. Immunoreactive proteins were detected by appropriate secondary HRP-conjugated antibodies (sheep anti-mouse Ig (Amersham Pharmacia Biotech, Arlington Heights, IL, USA), goat anti-rabbit Ig and rabbit anti-goat Ig (DAKO, Glostrup, Denmark)) and Super Signal detection system (Pierce Chemical Co., Rockford, IL, USA). Signal intensities were captured by charge coupled device (CCD) camera and quantified using Image Gauge software (Fujifilm, Tokyo, Japan).
Immunofluorescence and TUNEL staining For immunofluorescence, cells grown on cover slips were fixed in 4% paraformaldehyde and then blocked with 5% normal goat serum and 0.3% Triton X-100 in PBS for 30 min and washed in PBS. Fixed cells were incubated for 1 h with the same serum/antibodies used for Western blotting. Secondary goat-anti rabbit IgG antibodies conjugated to either Alexa Fluor 488 or Alexa Fluor 546 (Molecular Probes), diluted 1:400 in PBS, were used and cover slips were mounted in PVA-DABCO. TUNEL staining was performed according to the manufacturer's instructions (In Situ Cell Death Detection Kit, TMR red, Roche, Penzberg, Germany).
Confocal microscopy
Lysosomes were detected by incubating cells with 0.9 mM Lysotracker (Molecular Probes), thereafter the cells were washed in buffer H (20 mM HEPES, 137 mM NaCl, 3.7 mM KCl, 1.2 mM MgSO 4 , 2.2 mM KH 2 PO 4 , 1.6 mM CaCl 2 and 10 mM glucose at pH 7.4), mounted on the heated stage of a Nikon microscope and analysed by live confocal microscopy. Mitochondria were visualized by incubating living cells with 50 nM MT for 15 min at 371C, and fixed in 4% paraformaldehyde before analysis. The subcellular localization of EGFPtagged Bax, mitochondria, lysosomes and immunostained proteins was examined by using a Bio-Rad Radiance 2000 confocal system fitted on a Nikon microscope. A Â 60/NA 1.40 oil lens was used and excitation wavelengths were 488 nm (EGFP) and 543 nm (MR, Lysotracker Red, Alexa fluor 546). The 515HQ30 (EGFP) and 600LP (MR, Lysotracker Red, Alexa fluor 546) emission filters were used.
Plasmids, primers and quantitative real-time polymerase chain reaction cDNA encoding p21 Bax was generated by polymerase chain reaction (PCR) using cDNA from SK-N-BE(2)c cells as template, BglII and SalI sites were introduced in the primers, and these enzymes were then used for cloning into the pEGFP-C1 and -N1 vectors (Clontech, Mountain View, CA, USA). The generated constructs were sequenced to ensure that no mutations had been introduced. Constructs and primers used for generation of the plasmids are listed in Table 1a . The Bcl-2 expression plasmid was kindly provided by Dr Stanley Korsmeyer (Hockenbery et al., 1990) . For co-transfection experiments, the ratio SFFV to EGFP plasmids were 3:1. For quantitative real-time PCR, cDNA was synthesized using random hexamers and a superscript II reverse-transcriptase enzyme (Invitrogen). cDNA was used as template with SYBR Green PCR Master Mix from Applied Biosystems, as described in Vandesompele et al. (2002) . The comparative C T method was used for relative quantification of expression levels; gene expression levels were normalized to the expression of two housekeeping genes (YWHAZ and HPRT1). Primers, designed by use of Primer Express (Applied Biosystems) are listed in Table 1b. 
